Insulin glargine plus oral therapy in patients with type 2 diabetes allows flexible dosing and leads to improved metabolic control with less hypoglycemia versus NPH insulin

被引：0

|

作者：

Busch, K

Fritsche, A

Häring, HU

Schweitzer, MA

Vesper, I

机构：

来源：

DIABETES | 2003年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A443 / A443

页数：1

相关论文

共 50 条

[31] Better metabolic control, less hypoglycaemia and less weight gain with insulin detemir versus NPH insulin in intensive insulin therapy for patients with type 1 diabetes. A meta-analysis
Szypowska, A.
Golicki, D.
Groele, L.
Pankowska, E.
[J]. DIABETOLOGIA, 2009, 52 : S387 - S387
[32] Risk of exercise induced hypoglycemia in patients with diabetes mellitus type 2 (DM2) on intensified insulin therapy (ICT).: Comparison of NPH-insulin versus glargine as basal insulin supplement
Reuter, T
Topuz, M
Riese, B
Wiedenmann, B
Plöckinger, U
[J]. DIABETOLOGIA, 2005, 48 : A312 - A312
[33] Risk of exercise induced hypoglycemia in patients with diabetes mellitus type 2 (DM2) on intensified insulin therapy (ICT): Comparison of NPH-Insulin versus glargine as basal insulin supplement
Reuter, Thomas
Topuz, Mendaha
Riese, Brigitte
Wiedenmann, Bertram
Ploeckinger, Ursula
[J]. DIABETES, 2007, 56 : A280 - A280
[34] Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
Dailey, G. E.
Gao, L.
Aurand, L.
Garg, S. K.
[J]. DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1085 - 1092
[35] A meta-analysis of phase III/IIIb studies comparing insulin glargine with human NPH insulin in type 2 diabetes: Severe hypoglycemia is less common with glargine
Dailey, G
Riddle, M
Benedetti, MM
Fritsche, A
Lin, ZN
Salzman, A
[J]. DIABETES, 2003, 52 : A444 - A444
[36] Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland
Braendie, M.
Azoulay, M.
Greiner, R. -A.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (03) : 217 - 230
[37] Effect of insulin glargine and nph insulin on quality of life in patients with type 2 diabetes mellitus
Gupta, K. S.
Gupta, U.
[J]. VALUE IN HEALTH, 2007, 10 (03) : A70 - A70
[38] Comparing efficiency of insulin glargine vs. NPH insulin in patients with type 2 diabetes
Kodela, B.
Petrovic, J.
Velickovic-Radovanovic, R.
Lilic, R.
Radenkovic, S.
Dedovic, I
[J]. VALUE IN HEALTH, 2007, 10 (06) : A254 - A254
[39] Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy
Hollander, Priscilla
Sugimoto, Danny
Vlajnic, Aleksandra
Kilo, Charles
[J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1266 - 1271
[40] EFFECT OF INSULIN GLARGINE OR NPH INSULIN ON TREATMENT SATISFACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Moock, J.
Hessel, F.
Kohlmann, T.
[J]. VALUE IN HEALTH, 2008, 11 (06) : A514 - A514

← 1 2 3 4 5 →